$28.12

+0.12 (+0.43%)

Weekly Expected Move ±6.5%

$26 $28 $30 $32 $34

NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 28 · $806.4M mcap · 21M float · 1.19% daily turnover · Short 65% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE

37.6 / 100

NoneWeakNarrowWide

Primary source: Switching Costs · ROIC: -336.9%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. LBRX has No discernible competitive edge (37.6/100). The business operates without significant structural advantages. The primary source of advantage is Switching Costs. Negative ROIC of -336.9% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$37

Low

$37

Avg Target

$37

High

Based on 1 analyst since May 12, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 1Hold: 0Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$39.50

Analysts4

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-05-17	Roth Capital	—	$31	$37	+6	+24.7%	$29.66
2026-04-27	H.C. Wainwright	—	Initiated	$45	—	+46.4%	$30.73
2026-04-10	Craig-Hallum	—	Initiated	$36	—	+45.8%	$24.68
2026-03-27	Stifel Nicolaus	—	$35	$40	+5	+67.8%	$23.84
2026-01-09	Roth Capital	—	Initiated	$31	—	+49.0%	$20.80
2025-12-11	Stifel Nicolaus	—	$27	$35	+8	+63.9%	$21.36
2025-10-06	Leerink Partners	—	Initiated	$34	—	+125.9%	$15.05
2025-10-06	Stifel Nicolaus	—	Initiated	$27	—	+79.4%	$15.05

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+

May 22, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. LBRX receives an overall rating of C+. Strongest factors: D/E (4/5). Areas of concern: ROE (1/5), ROA (1/5), P/E (1/5).

Rating Change History

Date	From	To
2026-04-27	C	C+
2026-04-01	C+	C
2026-03-27	B-	C+
2026-01-14	C-	B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+

Profitability

—

Balance Sheet

Earnings Quality

Growth

—

Value

Momentum

—

Safety

100

Cash Flow

—

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

36.11

Safe Zone

Piotroski F-Score

1/9

✗ ✗ ✗ ✗ ✗ ✗ ✓ ✗ ✗

Beneish M-Score

—

Ohlson O-Score

-2.60

Bankruptcy prob: 6.9%

Low Risk

Credit Rating

A+

Score: 75.6/100

Earnings Quality

—

OCF/NI: 1.31x

Accruals: 3.4%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. LBRX scores 36.11, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. LBRX scores 1/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. LBRX's implied 6.9% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. LBRX receives an estimated rating of A+ (score: 75.6/100).

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

-20.27x

PEG

2.19x

P/S

0.00x

P/B

2.10x

P/FCF

-15.53x

P/OCF

—

EV/EBITDA

-10.30x

EV/Revenue

—

EV/EBIT

-10.24x

EV/FCF

-9.03x

Earnings Yield

-4.89%

FCF Yield

-6.44%

Shareholder Yield

0.00%

Graham Number

—

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. LBRX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

1.000

NI / EBT

Interest Burden

0.862

EBT / EBIT

EBIT Margin

—

EBIT / Rev

Asset Turnover

0.000

Rev / Assets

Equity Multiplier

1.039

Assets / Equity

ROE

-11.3%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. LBRX's ROE of -11.3% is driven by A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

—

Price/Value

—

Margin of Safety

—

Premium

—

Assessment

Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 176 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$28.12

Median 1Y

$45.81

5th Pctile

$15.62

95th Pctile

$134.51

Ann. Volatility

65.2%

Analyst Target

$39.50

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'25	Q4'25	Q1'26	Current
ROE	3.8%	-5.0%	-11.3%	-11.31%
ROA	-10.6%	-4.8%	-10.9%	-10.89%
ROIC	3.5%	-1.6%	-3.4%	-3.37%
ROCE	-14.0%	-5.7%	-12.9%	-12.94%
Gross Margin	—	—	—	—
Operating Margin	—	—	—	—
Net Margin	—	—	—	—
EBITDA Margin	—	—	—	—
FCF Margin	—	—	—	—
OCF Margin	—	—	—	—
ROIC Economic	snapshot only			-10.68%
Cash ROA	snapshot only			-14.31%
Cash ROIC	snapshot only			-4.63%
CROIC	snapshot only			-4.64%

Valuation

Metric	Q3'25	Q4'25	Q1'26	Current
P/E Ratio	-112.34	-37.47	-20.43	-20.274
P/S Ratio	—	—	—	0.000
P/B Ratio	-4.22	1.87	2.31	2.097
P/FCF	-118.43	-26.17	-15.53	-15.532
P/OCF	—	—	—	—
EV/EBITDA	-107.96	-15.73	-10.30	-10.305
EV/Revenue	—	—	—	—
EV/EBIT	-105.51	-15.58	-10.24	-10.240
EV/FCF	-111.23	-12.62	-9.03	-9.028
Earnings Yield	-0.9%	-2.7%	-4.9%	-4.89%
FCF Yield	-0.8%	-3.8%	-6.4%	-6.44%
PEG Ratio	snapshot only			2.194
Price/Tangible Book	snapshot only			2.311
Shareholder Yield	snapshot only			0.00%

Leverage & Solvency

Metric	Q3'25	Q4'25	Q1'26	Current
Current Ratio	3.56	41.44	41.44	41.445
Quick Ratio	3.56	41.44	41.44	41.445
Debt/Equity	-0.04	0.01	0.01	0.012
Net Debt/Equity	—	-0.97	-0.97	-0.968
Debt/Assets	0.11	0.01	0.01	0.011
Debt/EBITDA	-1.07	-0.21	-0.09	-0.091
Net Debt/EBITDA	6.99	16.90	7.42	7.424
Interest Coverage	—	—	—	—
Equity Multiplier	-0.35	1.04	1.04	1.039
Cash Ratio	snapshot only			39.669
Cash to Debt	snapshot only			82.716
FCF to Debt	snapshot only			-12.563
Defensive Interval	snapshot only			2624.5 days

Efficiency & Turnover

Metric	Q3'25	Q4'25	Q1'26	Current
Asset Turnover	0.00	0.00	0.00	0.000
Inventory Turnover	—	—	—	—
Receivables Turnover	—	—	—	—
Payables Turnover	0.03	0.04	0.08	0.077
DSO	—	—	—	—
DIO	0	0	0	0.0 days
DPO	10454	9585	4763	4762.9 days
Cash Conversion Cycle	—	—	—	—
Fixed Asset Turnover	snapshot only			0.000
Cash Velocity	snapshot only			0.000

Growth Quality

Metric	Q3'25	Q4'25	Q1'26	Current
Revenue Stability	—	—	—	—
Earnings Stability	—	—	—	—
Margin Stability	—	—	—	—
Rev. Growth Consistency	0.00	0.00	0.00	0.000
Earn. Growth Consistency	0.00	0.00	0.00	0.000
FCF Positive Streak	0	0	0	0
Earnings Persistence	—	—	—	—
Earnings Smoothness	—	—	—	—
ROE Trend	—	—	—	—
Gross Margin Trend	—	—	—	—
FCF Margin Trend	—	—	—	—
Sustainable Growth Rate	—	—	—	—
Internal Growth Rate	—	—	—	—

Cash Flow Quality

Metric	Q3'25	Q4'25	Q1'26	Current
OCF/Net Income	0.95	1.43	1.31	1.313
FCF/OCF	1.00	1.00	1.00	1.002
FCF/Net Income	snapshot only			1.316
CapEx/Revenue	—	—	—	—
CapEx/Depreciation	snapshot only			0.290
Accruals Ratio	-0.01	0.02	0.03	0.034
Sloan Accruals	snapshot only			0.020
Cash Flow Adequacy	snapshot only			-621.750

Dividends & Buybacks

Metric	Q3'25	Q4'25	Q1'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00
Payout Ratio	—	—	—	—
FCF Payout Ratio	—	—	—	—
Total Payout Ratio	—	—	—	—
Div. Increase Streak	—	—	—	—
Chowder Number	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.00%
Net Buyback Yield	-0.1%	-0.2%	-13.3%	-13.34%
Total Shareholder Return	-0.1%	-0.2%	-13.3%	-13.34%

DuPont Factors

Metric	Q3'25	Q4'25	Q1'26	Current
Tax Burden (NI/EBT)	1.00	1.00	1.00	1.000
Interest Burden (EBT/EBIT)	1.00	0.86	0.86	0.862
EBIT Margin	—	—	—	—
Asset Turnover	0.00	0.00	0.00	0.000
Equity Multiplier	-0.35	1.04	1.04	1.039

Per Share

Metric	Q3'25	Q4'25	Q1'26	Current
EPS (Diluted TTM)	$-0.14	$-0.59	$-1.21	$-1.21
Book Value/Share	$-3.74	$11.91	$10.67	$13.41
Tangible Book/Share	$-3.74	$11.91	$10.67	$10.67
Revenue/Share	$0.00	$0.00	$0.00	$0.00
FCF/Share	$-0.13	$-0.85	$-1.59	$-1.83
OCF/Share	$-0.13	$-0.85	$-1.59	$-1.83
Cash/Share	$1.11	$11.67	$10.45	$12.95
EBITDA/Share	$-0.14	$-0.68	$-1.39	$-1.39
Debt/Share	$0.15	$0.14	$0.13	$0.13
Net Debt/Share	$-0.96	$-11.53	$-10.33	$-10.33

Academic Models

Metric	Q3'25	Q4'25	Q1'26	Current
Altman Z-Score	—	—	—	36.106
Altman Z-Prime	snapshot only			67.021
Piotroski F-Score	2	1	1	1
Beneish M-Score	—	—	—	—
Ohlson O-Score	snapshot only			-2.604
ROIC (Greenblatt)	snapshot only			-12.97%
Net-Net WC	snapshot only			$10.51
EVA	snapshot only			$-33530400.00

Credit

Metric	Q3'25	Q4'25	Q1'26	Current
Credit Rating	snapshot only			A+
Credit Score	20.00	76.15	75.61	75.608
Credit Grade	snapshot only			5
Implied Spread (bps)	snapshot only			125.000
Industry Credit Rank	snapshot only			76
Sector Credit Rank	snapshot only			70

LBRX NASDAQ

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Sign in to InsiderStreet